JAGUAR HEALTH INC (JAGX) Stock Earnings & Estimates
NASDAQ:JAGX - US47010C8881 - Common Stock
1.67 USD
+0.04 (+2.45%)
1.7083 USD
+0.04 (+2.29%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 11.956M 175.80% | 9.761M -18.36% | 11.689M 19.75% | 14.308M 22.41% | 18.6M 30.00% | 204M 996.77% | 389.44M 90.90% | 573.95M 47.38% | 682.99M 19.00% | |
| EBITDA YoY % growth | -32.434M 13.17% | -31.907M 1.62% | -28.931M 9.33% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -34.415M 11.92% | -33.92M 1.44% | -30.831M 9.11% | -28.509M 7.53% | -23.633M 17.10% | 105.67M 547.12% | 260.3M 146.33% | 415.85M 59.76% | 509.49M 22.52% | |
| Operating Margin | -287.85% | -347.51% | -263.76% | -199.25% | -127.06% | 51.80% | 66.84% | 72.45% | 74.60% | |
| EPS YoY % growth | N/A 99.96% | N/A 89.90% | -232.59 -3,811.31% | -24.29 89.56% | -5.79 76.14% | N/A | N/A | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -5.18 80.26% | -4.35 -1,178.00% | -2.08 87.54% | -1.52 85.19% | -1.19 76.97% | -1.30 70.19% |
| Revenue Q2Q % growth | 3.805M 22.43% | 4.295M 23.95% | 3.741M 68.97% | 4.33M 47.48% | 4.945M 29.96% | 5.583M 29.99% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -6.64M 8.56% | -8.089M 0.84% | -5.62M 40.34% | -5.467M 17.92% | -5.375M 19.05% | -7.181M 11.22% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -10.26 89.84% | -7.27 | -2.99 | -41.08% |
| Q1 2025 Q2Q % growth | -16.70 84.10% | -18.36 | 1.66 | 9.04% |
| Q4 2024 Q2Q % growth | -0.34 65.99% | -18.87 | 18.53 | 98.20% |
| Q3 2024 Q2Q % growth | -26.25 96.82% | -60.44 | 34.19 | 56.56% |
| Q2 2024 Q2Q % growth | -101.00 90.24% | -30.60 | -70.40 | -230.07% |
| Q1 2024 Q2Q % growth | -105.00 -171,468.63% | -45.90 | -59.10 | -128.76% |
| Q4 2023 Q2Q % growth | 89.95% | -1.00 | % | |
| Q3 2023 Q2Q % growth | -825.00 93.89% | -1,881.90 | 1,056.90 | 56.16% |
| Q2 2023 Q2Q % growth | -1,035.00 92.33% | -2,340.90 | 1,305.90 | 55.79% |
| Q1 2023 Q2Q % growth | 100.00% | -0.06 | % | |
| Q4 2022 Q2Q % growth | 99.97% | -9.95 | % | |
| Q3 2022 Q2Q % growth | -13,500.00 55.56% | -8,606.25 | -4,893.75 | -56.86% |
| Q2 2022 Q2Q % growth | -13,500.00 60.00% | -25,245.00 | 11,745.00 | 46.52% |
| Q1 2022 Q2Q % growth | -45,000.00 -33.33% | -20,081.25 | -24,918.75 | -124.09% |
| Q4 2021 Q2Q % growth | -34,875.00 31.11% | -10,327.50 | -24,547.50 | -237.69% |
| Q3 2021 Q2Q % growth | -30,375.00 57.14% | -20,081.25 | -10,293.75 | -51.26% |
| Q2 2021 Q2Q % growth | -33,750.00 65.52% | -13,770.00 | -19,980.00 | -145.10% |
| Q1 2021 Q2Q % growth | -33,750.00 77.78% | -6,885.00 | -26,865.00 | -390.20% |
| Q4 2020 Q2Q % growth | -50,625.00 70.98% | -34,425.00 | -16,200.00 | -47.06% |
| Q3 2020 Q2Q % growth | -70,875.00 88.89% | -37,867.50 | -33,007.50 | -87.17% |
| Q2 2020 Q2Q % growth | -97,875.00 96.81% | -51,637.50 | -46,237.50 | -89.54% |
| Q1 2020 Q2Q % growth | -151,875.00 96.43% | -79,177.50 | -72,697.50 | -91.82% |
| Q3 2019 Q2Q % growth | -637,875.00 | -428,591.25 | -209,283.75 | -48.83% |
| Q2 2019 Q2Q % growth | -3,067,875.00 | -1,821,082.50 | -1,246,792.50 | -68.46% |
| Q1 2019 Q2Q % growth | -4,252,500.00 | -4,578,525.00 | 326,025.00 | 7.12% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 2.936M 7.90% | 3.33M | -394K | -11.83% |
| Q1 2025 Q2Q % growth | 2.214M -5.83% | 2.877M | -663K | -23.04% |
| Q4 2024 Q2Q % growth | 3.465M 50.65% | 3.193M | 272K | 8.52% |
| Q3 2024 Q2Q % growth | 3.108M 10.49% | 4.017M | -909K | -22.63% |
| Q2 2024 Q2Q % growth | 2.721M 1.68% | 3.494M | -773K | -22.12% |
| Q1 2024 Q2Q % growth | 2.351M 19.22% | 3.017M | -666K | -22.07% |
| Q4 2023 Q2Q % growth | 2.3M -29.45% | 2.662M | -362K | -13.60% |
| Q3 2023 Q2Q % growth | 2.813M -10.70% | 2.509M | 304K | 12.12% |
| Q2 2023 Q2Q % growth | 2.676M -8.39% | 2.326M | 350K | 15.05% |
| Q1 2023 Q2Q % growth | 1.972M -24.88% | 3.978M | -2.006M | -50.43% |
| Q4 2022 Q2Q % growth | 3.26M 56.73% | 2.04M | 1.22M | 59.80% |
| Q3 2022 Q2Q % growth | 3.15M 400.00% | 3.621M | -471K | -13.01% |
| Q2 2022 Q2Q % growth | 2.921M 658.70% | 3.162M | -241K | -7.62% |
| Q1 2022 Q2Q % growth | 2.625M 111.52% | 1.652M | 973K | 58.90% |
| Q4 2021 Q2Q % growth | 2.08M -19.25% | 8.548M | -6.468M | -75.67% |
| Q3 2021 Q2Q % growth | 630K -77.28% | 2.683M | -2.053M | -76.52% |
| Q2 2021 Q2Q % growth | 385K -87.84% | 5.049M | -4.664M | -92.37% |
| Q1 2021 Q2Q % growth | 1.241M 42.81% | 7.548M | -6.307M | -83.56% |
| Q4 2020 Q2Q % growth | 2.576M 70.92% | 2.346M | 230K | 9.80% |
| Q3 2020 Q2Q % growth | 2.773M 185.05% | 7.956M | -5.183M | -65.15% |
| Q2 2020 Q2Q % growth | 3.167M 85.67% | 4.874M | -1.707M | -35.02% |
| Q1 2020 Q2Q % growth | 869K -45.34% | 2.545M | -1.676M | -65.85% |
| Q4 2019 Q2Q % growth | 1.507M | 4.028M | -2.521M | -62.58% |
| Q3 2019 Q2Q % growth | 972.8K | 2.92M | -1.947M | -66.68% |
| Q2 2019 Q2Q % growth | 1.706M | 3.06M | -1.354M | -44.26% |
| Q1 2019 Q2Q % growth | 1.59M | 2.244M | -654.3K | -29.16% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 49.07% | 0% | 53.77% |
| Revenue | 0% | 0% | 0% | 0% |